• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Cell Rep . COVID-19 vaccination elicits an evolving, cross-reactive antibody response to epitopes conserved with endemic coronavirus spike proteins

tetano

Editor, Senior Moderator
Cell Rep


. 2022 Jun 13;111022.
doi: 10.1016/j.celrep.2022.111022. Online ahead of print.
COVID-19 vaccination elicits an evolving, cross-reactive antibody response to epitopes conserved with endemic coronavirus spike proteins


Evan A Elko[SUP] 1 [/SUP], Georgia A Nelson[SUP] 2 [/SUP], Heather L Mead[SUP] 2 [/SUP], Erin J Kelley[SUP] 2 [/SUP], Sophia T Carvalho[SUP] 2 [/SUP], Nathan G Sarbo[SUP] 2 [/SUP], Caroline E Harms[SUP] 2 [/SUP], Virginia Le Verche[SUP] 3 [/SUP], Angelo A Cardoso[SUP] 3 [/SUP], Jennifer L Ely[SUP] 2 [/SUP], Annalee S Boyle[SUP] 2 [/SUP], Alejandra Piña[SUP] 1 [/SUP], Sierra N Henson[SUP] 2 [/SUP], Fatima Rahee[SUP] 2 [/SUP], Paul S Keim[SUP] 1 [/SUP], Kimberly R Celona[SUP] 1 [/SUP], Jinhee Yi[SUP] 1 [/SUP], Erik W Settles[SUP] 1 [/SUP], Daniela A Bota[SUP] 4 [/SUP], George C Yu[SUP] 5 [/SUP], Sheldon R Morris[SUP] 6 [/SUP], John A Zaia[SUP] 3 [/SUP], Jason T Ladner[SUP] 1 [/SUP], John A Altin[SUP] 7 [/SUP]



Affiliations

Abstract

The COVID-19 pandemic has triggered the first widespread vaccination campaign against a coronavirus. Many vaccinated subjects are previously naive to SARS-CoV-2; however, almost all have previously encountered other coronaviruses (CoVs), and the role of this immunity in shaping the vaccine response remains uncharacterized. Here, we use longitudinal samples and highly multiplexed serology to identify mRNA-1273 vaccine-induced antibody responses against a range of CoV Spike epitopes, in both phylogenetically conserved and non-conserved regions. Whereas reactivity to SARS-CoV-2 epitopes shows a delayed but progressive increase following vaccination, we observe distinct kinetics for the endemic CoV homologs at conserved sites in Spike S2: these become detectable sooner and decay at later time points. Using homolog-specific antibody depletion and alanine-substitution experiments, we show that these distinct trajectories reflect an evolving cross-reactive response that can distinguish rare, polymorphic residues within these epitopes. Our results reveal mechanisms for the formation of antibodies with broad reactivity against CoVs.

Keywords: CP: Immunology; CP: Microbiology; SARS-CoV-2; multiplexed serology; vaccination.
 
Back
Top Bottom